Synergy Pharmaceuticals Logo Image

Synergy Pharmaceuticals

Synergy Pharmaceuticals has reached its limit for report views.

Please check back to see if Synergy Pharmaceuticals has upgraded their profile page to allow their financial information to be viewed. In the meantime, here are a few annual reports from similar companies.

Most Recent Annual Report

2015 Annual Report and Form 10K

Synergy Pharmaceuticals

Synergy Pharmaceuticals does not currently have any hardcopy reports available on AnnualReports.com. Click the button below to be notified when hardcopies become available.



Archived Annual Reports

About Synergy Pharmaceuticals

51-200 Employees
Based in New York City, New York

Synergy is a biopharmaceutical company focused on the development and commercialization of novel GI therapies. The company has pioneered discovery, research and development efforts around uroguanylin analogs for the treatment of functional GI disorders and inflammatory bowel disease. Synergy’s proprietary GI platform is based on uroguanylin and includes two lead product candidates – plecanatide and dolcanatide.

Ticker:
SGYP
Exchange:
NASDAQ (See More NASDAQ Companies)
Industry:
Drug Manufacturers - Other (See More Drug Manufacturers - Other Companies)
Sector:
Healthcare (See More Healthcare Companies)

Looking for Other Annual Reports?

Search by company name or ticker symbol